Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: First results

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 5, 2004, Pages 714-719

  Prigent Le Jeune, Florence ^a,b   Dubois, François ^a   Perez, Sarah ^a   Blond, Serge ^a   Steinling, Marc ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CENTRE EUGÈNE MARQUIS   (France)

Author keywords

Cerebral tumour; Chemosensitivity; Chemotherapy; MIBI

Indexed keywords

CARMUSTINE; FOTEMUSTINE; LOMUSTINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PROCARBAZINE; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DRUG RESPONSE; DRUG SENSITIVITY; DRUG UPTAKE; EVALUATION; FEMALE; GLIOMA; HUMAN; IMAGE ANALYSIS; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 2442492859     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1463-7     Document Type: Article

References (10)

1. Stewart LA. Chemotherapy in adult high grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 2002; 359:1011-1018.
2. 201Tl SPET imaging in the follow-up of treatment for brain tumour: a sensitive tool for the early identification of response to chemotherapy? Nucl Med Commun 2000; 21:259-267.
3. Roesdi MF, Postma TJ, Hoekstra OS, et al. Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma. J Neurooncol 1998; 40:251-255.
4. Koyuncu A, Kracht LW, Herholz K, et al. Monitoring the effect of chemotherapy in gliomas. Neuro-oncology 2000; 2:S40.
5. 18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas. Br J Cancer 2000; 82:608-615.
6. Lamy-Lhuillier C, Dubois F, Blond S, et al. Intérêt de la tomoscintigraphie cérébrale au sestamibi marqué au technétium dans le diagnostic différentiel récidive tumoraleradionécrose des tumeurs gliales sus-tentorielles de l'adulte. Neurochirurgie 1999; 45:10-117.
7. 99mTc-MIBI uptake. Nucl Med Commun 2002; 23:31-38.
8. 99mTc-sestamibi SPET? Eur J Nucl Med 1998; 25:401-409.
9. 99mTc-MIBI brain SPECT (functional index ratios) and survival after treatment failure in malignant glioma patients. Anticancer Res 2002; 22:3081-3085.
10. Soler C, Beauchesne P, Maatougui K, et al. Technetium-99m sestamibi brain single photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998; 25:1649-1657.